Literature DB >> 24530976

Obstetric antecedents to body-cooling treatment of the newborn infant.

David B Nelson1, Ashley M Lucke2, Donald D McIntire3, Pablo J Sánchez2, Kenneth J Leveno3, Lina F Chalak2.   

Abstract

OBJECTIVE: Obstetric antecedents were analyzed in births in which the infant received whole-body cooling for neonatal encephalopathy. STUDY
DESIGN: This retrospective cohort study included all live-born singleton infants delivered at or beyond 36 weeks' gestation from October 2005 through December 2011. Infants who had received whole-body cooling identified by review of a prospective neonatal registry were compared with a control group comprising the remaining obstetric population delivered at greater than 36 weeks but not cooled. Univariable analysis was followed up by a staged, stepwise selection of variables with the intent to rank significant risk factors for cooling.
RESULTS: A total of 86,371 women delivered during the study period and 98 infants received whole-body cooling (1.1 per 1000 live births). Of these 98 infants, 80 newborns (88%) had moderate encephalopathy and 10 (12%) had severe encephalopathy prior to cooling. Maternal age of 15 years or younger, low parity, maternal body habitus (body mass index of ≥40 kg/m(2)), diabetes, preeclampsia, induction, epidural analgesia, chorioamnionitis, length of labor, and mode of delivery were associated with significantly increased risk of infant cooling during a univariable analysis. Catastrophic events to include umbilical cord prolapse (odds ratio [OR], 14; 95% confidence interval [CI], 3-72), placental abruption (OR, 17; 95% CI, 7-44), uterine rupture (OR, 130; 95% CI, 11-1477) were the strongest factors associated with infant cooling after staged-stepwise logistic analysis.
CONCLUSION: A variety of intrapartum characteristics were associated with infant cooling for neonatal encephalopathy, with the most powerful antecedents being umbilical cord prolapse, placental abruption, and uterine rupture.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  perinatal acidemia; systemic hypothermia

Mesh:

Year:  2014        PMID: 24530976      PMCID: PMC4117807          DOI: 10.1016/j.ajog.2014.02.013

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  30 in total

1.  Risk factors for acidemia at birth.

Authors:  A Herbst; P Wolner-Hanssen; I Ingemarsson
Journal:  Obstet Gynecol       Date:  1997-07       Impact factor: 7.661

2.  School performance of survivors of neonatal encephalopathy associated with birth asphyxia at term.

Authors:  C M Robertson; N N Finer; M G Grace
Journal:  J Pediatr       Date:  1989-05       Impact factor: 4.406

3.  Antecedents of cerebral palsy. Multivariate analysis of risk.

Authors:  K B Nelson; J H Ellenberg
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

4.  Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs.

Authors:  A J Gunn; T R Gunn; H H de Haan; C E Williams; P D Gluckman
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

5.  The effect of prolonged modification of cerebral temperature on outcome after hypoxic-ischemic brain injury in the infant rat.

Authors:  E S Sirimanne; R M Blumberg; D Bossano; M Gunning; A D Edwards; P D Gluckman; C E Williams
Journal:  Pediatr Res       Date:  1996-04       Impact factor: 3.756

6.  Perinatal observations in forty-eight neurologically impaired term infants.

Authors:  J P Phelan; M O Ahn
Journal:  Am J Obstet Gynecol       Date:  1994-08       Impact factor: 8.661

7.  Specific inhibition of apoptosis after cerebral hypoxia-ischaemia by moderate post-insult hypothermia.

Authors:  A D Edwards; X Yue; M V Squier; M Thoresen; E B Cady; J Penrice; C E Cooper; J S Wyatt; E O Reynolds; H Mehmet
Journal:  Biochem Biophys Res Commun       Date:  1995-12-26       Impact factor: 3.575

8.  Cardiopulmonary resuscitation in the delivery room. Associated clinical events.

Authors:  J M Perlman; R Risser
Journal:  Arch Pediatr Adolesc Med       Date:  1995-01

9.  Mild hypothermia after severe transient hypoxia-ischemia ameliorates delayed cerebral energy failure in the newborn piglet.

Authors:  M Thoresen; J Penrice; A Lorek; E B Cady; M Wylezinska; V Kirkbride; C E Cooper; G C Brown; A D Edwards; J S Wyatt
Journal:  Pediatr Res       Date:  1995-05       Impact factor: 3.756

10.  Can asphyxiated infants at risk for neonatal seizures be rapidly identified by current high-risk markers?

Authors:  J M Perlman; R Risser
Journal:  Pediatrics       Date:  1996-04       Impact factor: 7.124

View more
  5 in total

Review 1.  Maternal, Labor, Delivery, and Perinatal Outcomes Associated with Placental Abruption: A Systematic Review.

Authors:  Katheryne L Downes; Katherine L Grantz; Edmond D Shenassa
Journal:  Am J Perinatol       Date:  2017-03-22       Impact factor: 1.862

2.  Acute Perinatal Sentinel Events, Neonatal Brain Injury Pattern, and Outcome of Infants Undergoing a Trial of Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy.

Authors:  Seetha Shankaran; Abbot R Laptook; Scott A McDonald; Susan R Hintz; Patrick D Barnes; Abhik Das; Rosemary D Higgins
Journal:  J Pediatr       Date:  2016-10-21       Impact factor: 4.406

3.  A descriptive study of suspected perinatal asphyxia at Mitchells Plain District Hospital: A case series.

Authors:  Johannes P J Stofberg; Graeme W Spittal; Tracey Hinkel; Tasleem Ras
Journal:  S Afr Fam Pract (2004)       Date:  2020-10-09

Review 4.  Neonatal Encephalopathy: Need for Recognition of Multiple Etiologies for Optimal Management.

Authors:  Saima Aslam; Tammy Strickland; Eleanor J Molloy
Journal:  Front Pediatr       Date:  2019-04-16       Impact factor: 3.418

5.  Is perinatal asphyxia predictable?

Authors:  Anna Locatelli; Laura Lambicchi; Maddalena Incerti; Francesca Bonati; Massimo Ferdico; Silvia Malguzzi; Ferruccio Torcasio; Patrizia Calzi; Tiziana Varisco; Giuseppe Paterlini
Journal:  BMC Pregnancy Childbirth       Date:  2020-03-30       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.